Intracellular cargo delivery by virus capsid protein-based vehicles: From nano to micro

Chou, 2011, Strategies for the intracellular delivery of nanoparticles, Chem Soc Rev, 40, 233, 10.1039/C0CS00003E Shin, 2014, Cell-penetrating peptides: achievements and challenges in application for cancer treatment, J Biomed Mater Res A, 102, 575, 10.1002/jbm.a.34859 Koren, 2012, Cell-penetrating peptides: breaking through to the other side, Trends Mol Med, 18, 385, 10.1016/j.molmed.2012.04.012 Zhao, 2004, Intracellular cargo delivery using tat peptide and derivatives, Med Res Rev, 24, 1, 10.1002/med.10056 Gupta, 2005, Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides, Adv Drug Deliv Rev, 57, 637, 10.1016/j.addr.2004.10.007 Milletti, 2012, Cell-penetrating peptides: classes, origin, and current landscape, Drug Discov Today, 17, 850, 10.1016/j.drudis.2012.03.002 Lindgren, 2011, Classes and prediction of cell-penetrating peptides, Methods Mol Biol, 683, 3, 10.1007/978-1-60761-919-2_1 Li, 2009, Imaging viral behavior in mammalian cells with self-assembled capsid-quantum-dot hybrid particles, Small, 5, 718, 10.1002/smll.200801303 Gao, 2005, In vivo molecular and cellular imaging with quantum dots, Curr Opin Biotechnol, 16, 63, 10.1016/j.copbio.2004.11.003 Gao, 2007, Quantum dots for in vivo molecular and cellular imaging, Methods Mol Biol, 374, 135 Shokrollahi, 2013, Contrast agents for MRI, Mater Sci Eng C Mater Biol Appl, 33, 4485, 10.1016/j.msec.2013.07.012 Zhao, 2014, Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent, J Nanosci Nanotechnol, 14, 210, 10.1166/jnn.2014.9192 Lim, 2011, Gold nanoparticles in cancer therapy, Acta Pharmacol Sin, 32, 983, 10.1038/aps.2011.82 Llevot, 2012, Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer, Chem Soc Rev, 41, 242, 10.1039/C1CS15080D Thorek, 2008, Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells, Biomaterials, 29, 3583, 10.1016/j.biomaterials.2008.05.015 Williams, 2007, MRI detection of macrophages labeled using micrometer-sized iron oxide particles, J Magn Reson Imaging, 25, 1210, 10.1002/jmri.20930 Shapiro, 2007, Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI, Contrast Media Mol Imaging, 2, 147, 10.1002/cmmi.134 Sun, 2007, Core-controlled polymorphism in virus-like particles, Proc Natl Acad Sci U S A, 104, 1354, 10.1073/pnas.0610542104 Douglas, 1998, Host-guest encapsulation of materials by assembled virus protein cages, Nature, 393, 152, 10.1038/30211 Loo, 2007, Encapsidation of nanoparticles by red clover necrotic mosaic virus, J Am Chem Soc, 129, 11111, 10.1021/ja071896b Goicochea, 2007, Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates, Nano Lett, 7, 2281, 10.1021/nl070860e Loo, 2006, Controlled encapsidation of gold nanoparticles by a viral protein shell, J Am Chem Soc, 128, 4502, 10.1021/ja057332u Mikkila, 2014, Virus-encapsulated DNA origami nanostructures for cellular delivery, Nano Lett, 14, 2196, 10.1021/nl500677j Rurup, 2014, Predicting the loading of virus-like particles with fluorescent proteins, Biomacromolecules, 15, 558, 10.1021/bm4015792 Huang, 2007, Self-assembled virus-like particles with magnetic cores, Nano Lett, 7, 2407, 10.1021/nl071083l Rayment, 1982, Polyoma-virus capsid structure at 22.5-a resolution, Nature, 295, 110, 10.1038/295110a0 Salunke, 1989, Polymorphism in the assembly of polyomavirus capsid protein Vp1, Biophys J, 56, 887, 10.1016/S0006-3495(89)82735-3 Salunke, 1986, Self-assembly of purified polyomavirus capsid protein-Vp1, Cell, 46, 895, 10.1016/0092-8674(86)90071-1 Li, 2010, Viral coat proteins as flexible nano-building-blocks for nanoparticle encapsulation, Small, 6, 2301, 10.1002/smll.201001078 Wang, 2011, Encapsulation of gold nanoparticles by simian virus 40 capsids, Nanoscale, 3, 4275, 10.1039/c1nr10568j Kimchi-Sarfaty, 2004, SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy, Curr Pharm Biotechnol, 5, 451, 10.2174/1389201043376670 Takahashi, 2008, Presentation of functional foreign peptides on the surface of SV40 virus-like particles, J Biotechnol, 135, 385, 10.1016/j.jbiotec.2008.05.012 Pelkmans, 2001, Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER, Nat Cell Biol, 3, 473, 10.1038/35074539 Chen, 2013, Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics, Int J Nanomedicine, 8, 2677, 10.2147/IJN.S45429 Akhter, 2013, Nanomedicines as cancer therapeutics: current status, Curr Cancer Drug Targets, 13, 362, 10.2174/1568009611313040002 Huang, 2011, Inorganic nanoparticles for cancer imaging and therapy, J Control Release, 155, 344, 10.1016/j.jconrel.2011.06.004 Sanvicens, 2008, Multifunctional nanoparticles — properties and prospects for their use in human medicine, Trends Biotechnol, 26, 425, 10.1016/j.tibtech.2008.04.005 Daniels, 2006, SV40 VP2 and VP3 insertion into ER membranes is controlled by the capsid protein VP1: implications for DNA translocation out of the ER, Mol Cell, 24, 955, 10.1016/j.molcel.2006.11.001 Damm, 2005, Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae, J Cell Biol, 168, 477, 10.1083/jcb.200407113